HONG KONG – Some outward-looking Indian drugmakers may be benefiting from the cheapest rupee ever, but others, which hedged their currency bets, could take a hit.
HONG KONG – Some outward-looking Indian drugmakers may be benefiting from the cheapest rupee ever, but others, which hedged their currency bets, could take a hit.
HONG KONG – China-based Hansoh Pharmaceutical Group Co. Ltd. filed for an IPO in Hong Kong late last week, making it the 11th biopharma company to seek a listing on the Hong Kong Stock Exchange (HKEX) since May and following Ascentage Pharma Group International's IPO a week earlier.
HONG KONG – Hong Kong Exchanges and Clearing (HKEX) has revised its IPO rules to allow not-yet-profitable biotech companies go public in the city. That is likely to revive the biotechnology sector in Hong Kong's stock market, which hasn't attracted much interest in the past decade.
HONG KONG – Hong Kong Exchanges and Clearing (HKEX) has revised its IPO rules to allow not-yet-profitable biotech companies go public in the city. That is likely to revive the biotechnology sector in Hong Kong's stock market, which hasn't attracted much interest in the past decade.
